Shanghai, China

Shumei You

This inventor holds 1 USPTO granted patent and 6 published patent applications. Top assignee: Shanghai Cell Therapy Group Co., Ltd.. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shumei You: Innovator in Cell Therapy

Introduction

Shumei You is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of cell therapy, particularly in the development of innovative treatments for malignant tumors. His work focuses on enhancing the efficacy of T cell therapies through advanced genetic modifications.

Latest Patents

Shumei You holds a patent for an "Antibody-modified chimeric antigen receptor modified T cell and uses thereof." This invention involves a T cell that expresses an antibody or contains the coding sequence of the antibody. The antibody includes an optional signal peptide, an antigen binding sequence, and a mutant type Fc segment. The mutant type Fc segment features specific amino acid mutations at the 17th and 79th sites of the IgG4 Fc segment. Notably, the T cell is designed to be a CAR-T cell, which is pivotal in treating malignant tumors.

Career Highlights

Shumei You is associated with Shanghai Cell Therapy Group Co., Ltd., where he continues to advance research in cell therapy. His innovative approaches have positioned him as a key figure in the development of next-generation cancer treatments. His work is characterized by a commitment to improving patient outcomes through scientific innovation.

Collaborations

Shumei You collaborates with esteemed colleagues, including Qijun Qian and Huajun Jin. Their combined expertise enhances the research and development efforts within the field of cell therapy.

Conclusion

Shumei You's contributions to the field of cell therapy exemplify the impact of innovative thinking in medical science. His patent and ongoing work are crucial in the fight against malignant tumors, showcasing the potential of advanced T cell therapies.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…